Related references
Note: Only part of the references are listed.Serum levels of YKL-40 increases in patients with acute myocardial infarction
Camilla Nojgaard et al.
CORONARY ARTERY DISEASE (2008)
Markers of endothelial dysfunction and inflammation in type 1 diabetic patients with or without diabetic nephropathy followed for 10 years - Association with mortality and decline of glomerular filtration rate
Anne Sofie Astrup et al.
DIABETES CARE (2008)
YKL-40 protein expression is not a prognostic marker in patients with primary breast cancer
Anne Roslind et al.
BREAST CANCER RESEARCH AND TREATMENT (2008)
Evidence of increased inflammation and microcirculatory abnormalities in patients with type 1 diabetes and their role in microvascular complications
Sridevi Devaraj et al.
DIABETES (2007)
Serum YKL-40 levels in patients with coronary artery disease
Mine Kucur et al.
CORONARY ARTERY DISEASE (2007)
Substrate source utilisation in long-term diagnosed type 2 diabetes patients at rest, and during exercise and subsequent recovery
H. Boon et al.
DIABETOLOGIA (2007)
YKL-40, a biomarker of inflammation, is elevated in patients with type 2 diabetes and is related to insulin resistance
CN Rathcke et al.
INFLAMMATION RESEARCH (2006)
YKL-40, a new inflammatory marker with relation to insulin resistance and with a role in endothelial dysfunction and atherosclerosis
C. N. Rathcke et al.
INFLAMMATION RESEARCH (2006)
Progression of microalbuminuria in type 1 diabetes: Ten-year prospective observational study
P Rossing et al.
KIDNEY INTERNATIONAL (2005)
Vascular complications in diabetes mellitus: the role of endothelial dysfunction
CG Schalkwijk et al.
CLINICAL SCIENCE (2005)
Markers of inflammation are cross-sectionally associated with microvascular complications and cardiovascular disease in type 1 diabetes - the EURODIAB Prospective Complications Study
MT Schram et al.
DIABETOLOGIA (2005)
Mortality from heart disease in a cohort of 23,000 patients with insulin-treated diabetes
SP Laing et al.
DIABETOLOGIA (2003)
Decreasing incidence of severe diabetic microangiopathy in type 1 diabetes
P Hovind et al.
DIABETES CARE (2003)
C-reactive protein and soluble vascular cell adhesion molecule-1 are associated with elevated urinary albumin excretion but do not explain its link with cardiovascular risk
A Jager et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2002)
Inflammation and atherosclerosis
P Libby et al.
CIRCULATION (2002)
Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals
HC Gerstein et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2001)
Share Paper
